REG - JP Morgan Sec LLC Willis Towers Watson - Willis Towers Watson plc 8.3

Willis Towers WatsonAnnouncement

09/06/2021 14:00

RNS Number : 3617B
  
J.P. Morgan Securities LLC
  
09 June 2021
  
 

Ap19
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


J.P. Morgan Securities LLC




Company dealt in


Willis Towers Watson plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.000304635 ordinary shares




Date of dealing


08 June 2021




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


1,909,035                1.48
 


1,629,021             1.26
 




(2) Derivatives (other than options)


1,466,816                1.14
 


1,727,587                1.34
 




(3) Options and agreements to purchase/sell
 


14,000             0.01
 


 




Total


3,389,851             2.63
 


3,356,608             2.60
 



 
 
 
 
 
 
 



 

 

Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 




 
Purchase/sale


 
Number of relevant securities


 
Price per unit (USD)
 
(Note 5)




Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
 
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales


1,780 
 1 
 1 
 3,877 
 1,161 
 73 
 100 
 200 
 9 
 2 
 60 
 
 1,780 
 1 
 74,038 
 73 
 1,649 
 179 
 239 
 4 
 100 
 300 
 900 
 200 
 2 
 2 
 10 
 90 
 4 
 4 
 120


256.9900     USD
255.0800     USD
255.0700     USD
254.5700     USD
254.5660     USD
254.5000     USD
254.3700     USD
254.3600     USD
254.0100     USD
253.7350     USD
252.5900     USD
                        
256.9900     USD
255.0800     USD
254.5700     USD
254.5000     USD
254.4718     USD
254.4556     USD
254.4209     USD
254.3875     USD
254.3700     USD
254.3600     USD
254.1933     USD
253.9550     USD
253.7450     USD
253.7350     USD
253.6300     USD
253.5700     USD
253.1850     USD
252.7000     USD
252.5900     USD




 
 
 
 
 
 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(USD) (Note 5)




Equity Swap


Increase Long
 
Decrease Short


71,100 
 
 60


254.5700     USD
                        
252.5900     USD




 
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price (USD)


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5) (USD)




 


 


 


 


 


 


 




 
 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 




 
                          
 
Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and 
any other person relating to the voting rights of any relevant securities under any option referred to 
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 
which any derivative referred to on this form is referenced. If none, this should be stated.
 
     None
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            Yes
 




Date of disclosure


09 June 2021




Contact name


Alwyn Basch




Telephone number


0207 742 7407




If a connected EFM, name of offeree/offeror with which connected


N/A




If a connected EFM, state nature of connection (Note 10)


N/A




 
 
 
 
 
 
 
SUPPLEMENTAL FORM 8
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
 
 
 
DETAILS OF OPEN POSITIONS
 
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
 
OPEN POSITIONS (Note 1)
 
 
 




Product name,
e.g. call option


Written, or purchased


Number of relevant securities to which the option or derivative relates


Exercise price (Note 2) (USD)


Type, e.g. American, European etc.


Expiry date




Call Option
Put Option
Put Option


Purchased
Purchased
Purchased


2,000
2,000
10,000


290.00
230.00
260.00


American
American
American


18/06/2021
18/06/2021
18/06/2021




 
 
Notes
 
1.          Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
 
2.          For all prices and other monetary amounts, the currency must be stated.
 
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISELKLFBFQLEBBD